RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets

Vicapsys Life Sciences (OTC: VICP) completed its reverse merger with Stateline Distributors of Puerto Rico, effective September 3, 2026, making Stateline a wholly owned subsidiary and giving VICP a licensed wholesale drug distribution business with roughly 400 active healthcare accounts in Puerto Rico and a 50-state title model via 3PL partner Drugzone. VICP signed a definitive agreement to acquire NitroMist, an FDA-approved but discontinued nitroglycerin lingual aerosol (NDA 021780), from KCK Sunshine for a $2.0 million convertible note bearing 15% interest, convertible at $1.00 per share; closing remains subject to FDA acknowledgment of the NDA transfer.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.